IRISH TAKEOVER PANEL
Disclosure Table

The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:

_______________________________________________________________

Offeree: Horizon Therapeutics plc

Offer period commenced: 29 November 2022

$0.0001 ordinary shares; ISIN: IE00BQPVQZ61; NSI: 226,682,814

Offeror: Amgen Inc

Disclosure of dealings and positions in this offeror is not required

Offeror: Sanofi

Disclosure of dealings and positions in this offeror is not required

Offerors identified: 29 November 2022

Rule 2.6(a) deadline: 17.00 (New York time) 10 January 2023

Irish Takeover Panel 5 December 2022

Lower Ground Floor

76 Merrion Square

Dublin D02 X4T1

Telephone: + 353-1-678 9020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END